BREMNER CAPITAL MANAGEMENT Tekmira Pharmaceuticals March 2014 • TKM — ALDH2 is a unique application of RNAi and is designed to knockdown the Aldehyde dehydrogenase 2 (ALDH2) enzyme to induce long term sensitivity to ethanol. By silencing this enzyme the levels of acetaldehyde are higher and that